| Sorafenib Tosylate studied in …STUDIED_INderived135 of 135show fewer |
|---|
| → studied in | NCT00874874Phase 2 · completed Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery · 135 trials list this drug (3 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01303341Phase 1 · active not recruiting Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma · 135 trials list this drug (3 active) | — | — | Malignant Solid Neoplasm,Melanoma,Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01861314Phase 1 · active not recruiting Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia · 135 trials list this drug (3 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia Post Cytotoxic Therapy+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00265798Phase 2 · active not recruiting Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate · 135 trials list this drug (3 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01015833Phase 3 · completed Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer · 135 trials list this drug (3 active) | — | — | Hepatocellular Carcinoma,Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02066181Phase 3 · completed Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis · 135 trials list this drug (3 active) | — | — | Desmoid Fibromatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00326898Phase 3 · completed Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery · 135 trials list this drug (3 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01371981Phase 3 · completed Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · 135 trials list this drug (3 active) | — | — | Myeloid Neoplasm,Myeloid Sarcoma,Leukemia Cutis+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00939627Phase 2 · completed Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab · 135 trials list this drug (3 active) | — | — | Malignant Salivary Gland Neoplasm,Laryngeal Squamous Cell Carcinoma,Laryngeal Verrucous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03211416Phase 1/Phase 2 · completed Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer · 135 trials list this drug (3 active) | — | — | Hepatocellular Carcinoma,Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00826540Phase 2 · completed Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer · 135 trials list this drug (3 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02143401Phase 1 · completed Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors · 135 trials list this drug (3 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Malignant Solid Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01817751Phase 2 · completed Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma · 135 trials list this drug (3 active) | — | — | Glioblastoma,Malignant Glioma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01578109Phase 1 · completed Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia · 135 trials list this drug (3 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02135874Phase 2 · completed Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia · 135 trials list this drug (3 active) | — | — | Acute Leukemia of Ambiguous Lineage,Acute Undifferentiated Leukemia,Mixed Phenotype Acute Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096434Phase 2 · completed Sorafenib in Treating Patients With Metastatic Breast Cancer · 135 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390325Phase 2 · completed Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer · 135 trials list this drug (3 active) | — | — | Hereditary Thyroid Gland Medullary Carcinoma,Multiple Endocrine Neoplasia Type 2A,Multiple Endocrine Neoplasia Type 2B+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01004978Phase 3 · completed Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery · 135 trials list this drug (3 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01624285Phase 2 · completed Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer · 135 trials list this drug (3 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093457Phase 2 · completed Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer · 135 trials list this drug (3 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00981162Phase 1 · completed Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride · 135 trials list this drug (3 active) | — | — | Adult Solid Neoplasm,Malignant Pancreatic Neoplasm,Pancreatic Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01253070Phase 2 · completed Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia · 135 trials list this drug (3 active) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy,Acute Myeloid Leukemia with FLT3/ITD Mutation,Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02072486NA · completed Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery · 135 trials list this drug (3 active) | — | — | Childhood Hepatocellular Carcinoma,Hepatocellular Carcinoma,Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602576Phase 2 · completed Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma · 135 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664182Phase 2 · completed Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer · 135 trials list this drug (3 active) | — | — | Sarcomatoid Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00867321Phase 1/Phase 2 · completed Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer · 135 trials list this drug (3 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02050919Phase 2 · completed Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma · 135 trials list this drug (3 active) | — | — | Adult Soft Tissue Sarcoma,Pleomorphic Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00589420Phase 2 · completed Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy · 135 trials list this drug (3 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096200Phase 2 · completed Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer · 135 trials list this drug (3 active) | — | — | Primary Peritoneal Carcinoma,Ovarian Carcinoma,Fallopian Tube Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01900002Phase 2 · completed Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery · 135 trials list this drug (3 active) | — | — | Hepatocellular Carcinoma,Adult Hepatocellular Carcinoma,BCLC Stage C Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01620216Phase 2 · terminated Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia · 135 trials list this drug (3 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00121251Phase 1/Phase 2 · completed Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer · 135 trials list this drug (3 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445080Phase 1/Phase 2 · completed Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia · 135 trials list this drug (3 active) | — | — | Childhood Solid Neoplasm,Juvenile Myelomonocytic Leukemia,Childhood Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01666756Phase 1 · completed Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer · 135 trials list this drug (3 active) | — | — | Hepatocellular Carcinoma,Adult Hepatocellular Carcinoma,BCLC Stage B Adult Hepatocellular Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01531361Phase 1 · completed Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations · 135 trials list this drug (3 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00622466Phase 2 · terminated Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer · 135 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02779283Phase 1 · completed Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia · 135 trials list this drug (3 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01075555Phase 3 · completed Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis · 135 trials list this drug (3 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01497444Phase 1 · completed Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery · 135 trials list this drug (3 active) | — | — | Malignant Kidney Neoplasm,Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00687674Phase 1 · terminated Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma · 135 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01075113Phase 1 · completed Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer · 135 trials list this drug (3 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093626Phase 2 · completed Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer · 135 trials list this drug (3 active) | — | — | Primary Peritoneal Carcinoma,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00941967Phase 2 · completed Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer · 135 trials list this drug (3 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00869570Phase 1/Phase 2 · completed External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer · 135 trials list this drug (3 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005199Phase 2 · completed Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer · 135 trials list this drug (3 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00499525Phase 2 · unknown Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer · 135 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00547443Phase 1/Phase 2 · withdrawn Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer · 135 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126659Phase 2 · terminated Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer · 135 trials list this drug (3 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00378703Phase 2 · completed Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer · 135 trials list this drug (3 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00329719Phase 1/Phase 2 · completed Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma · 135 trials list this drug (3 active) | — | — | Adult Glioblastoma,Adult Brain Neoplasm,Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00822848Phase 1 · completed Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma · 135 trials list this drug (3 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112671Phase 2 · completed Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract · 135 trials list this drug (3 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00335764Phase 1/Phase 2 · completed Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma · 135 trials list this drug (3 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01502410Phase 2 · completed Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer · 135 trials list this drug (3 active) | — | — | Childhood Hepatocellular Carcinoma,Childhood Malignant Liver Neoplasm,Malignant Thyroid Gland Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02035527Phase 1 · completed Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · 135 trials list this drug (3 active) | — | — | Malignant Salivary Gland Neoplasm,Laryngeal Squamous Cell Carcinoma,Laryngeal Verrucous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00621686Phase 2 · completed Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme · 135 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01135056Phase 3 · unknown Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC) · 135 trials list this drug (3 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00722072Phase 2 · terminated Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy · 135 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126568Phase 2 · terminated Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer · 135 trials list this drug (3 active) | — | — | Malignant Thyroid Gland Neoplasm,Thyroid Gland Anaplastic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01011010Phase 1 · completed Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery · 135 trials list this drug (3 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387751Phase 2 · completed Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma · 135 trials list this drug (3 active) | — | — | Melanoma,Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00466752Phase 2 · completed Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer · 135 trials list this drug (3 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00881751Phase 2 · completed Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer · 135 trials list this drug (3 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01276210Phase 1 · completed Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases · 135 trials list this drug (3 active) | — | — | Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00244972Phase 1 · completed Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer · 135 trials list this drug (3 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01383343Phase 1 · completed Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer · 135 trials list this drug (3 active) | — | — | Colon Carcinoma,Malignant Colon Neoplasm,Malignant Rectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00405366early Phase 1 · completed Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer · 135 trials list this drug (3 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454194Phase 2 · completed Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 135 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00828074Phase 1/Phase 2 · completed Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer · 135 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098540Phase 2 · completed Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 135 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126594Phase 2 · completed Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer · 135 trials list this drug (3 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01576185completed Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia · 135 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01008566Phase 1 · completed Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer · 135 trials list this drug (3 active) | — | — | Adult Liver Carcinoma,Hepatocellular Carcinoma,Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445588Phase 2 · completed Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme · 135 trials list this drug (3 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00522301Phase 2 · terminated Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission · 135 trials list this drug (3 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01450384Phase 1 · completed Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors · 135 trials list this drug (3 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00573755Phase 2 · terminated Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer · 135 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238121Phase 2 · completed Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer · 135 trials list this drug (3 active) | — | — | Uterine Corpus Sarcoma,Uterine Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00110019Phase 3 · completed Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery · 135 trials list this drug (3 active) | — | — | Melanoma,Cutaneous Melanoma,Mucosal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00131937Phase 2 · completed Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma · 135 trials list this drug (3 active) | — | — | Anaplastic Large Cell Lymphoma,Adult T-Cell Leukemia/Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126620Phase 1 · completed Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors · 135 trials list this drug (3 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093222Phase 2 · completed Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma · 135 trials list this drug (3 active) | — | — | Gallbladder Adenosquamous Carcinoma,Gallbladder Carcinoma,Gallbladder Undifferentiated Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217646Phase 1 · completed Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia · 135 trials list this drug (3 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Secondary Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00255658Phase 1 · completed Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors · 135 trials list this drug (3 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01851408Phase 2 · withdrawn Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma · 135 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00844168Phase 1 · completed Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant · 135 trials list this drug (3 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00565968Phase 1 · completed Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg · 135 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126503Phase 1/Phase 2 · completed Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer · 135 trials list this drug (3 active) | — | — | Sarcomatoid Renal Cell Carcinoma,Clear Cell Renal Cell Carcinoma,Papillary Renal Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114244Phase 2 · completed Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer · 135 trials list this drug (3 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01158287Phase 2 · completed Sorafenib. ICORG 06-41, V4 · 135 trials list this drug (3 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00726986Phase 2 · terminated Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer · 135 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00131911Phase 2 · completed Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors · 135 trials list this drug (3 active) | — | — | Neuroendocrine Tumor,Digestive System Neuroendocrine Tumor G1,Gastrin-Producing Neuroendocrine Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00329641Phase 2 · completed Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye · 135 trials list this drug (3 active) | — | — | Uveal Melanoma,Iris Melanoma,Medium/Large Size Posterior Uveal Melanoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866320Phase 2 · completed Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab · 135 trials list this drug (3 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00121264Phase 1 · completed 17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors · 135 trials list this drug (3 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093613Phase 1 · completed Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma · 135 trials list this drug (3 active) | — | — | Adult Anaplastic Astrocytoma,Adult Anaplastic Oligodendroglioma,Adult Giant Cell Glioblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112905Phase 2 · terminated Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium · 135 trials list this drug (3 active) | — | — | Bladder Squamous Cell Carcinoma,Malignant Bladder Neoplasm,Malignant Urethral Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217399Phase 1/Phase 2 · completed Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer · 135 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245102Phase 2 · completed Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma · 135 trials list this drug (3 active) | — | — | Malignant Peripheral Nerve Sheath Tumor,Adult Soft Tissue Sarcoma,Ovarian Sarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00182689Phase 2 · completed Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer · 135 trials list this drug (3 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00281957Phase 2 · completed Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery · 135 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00303966Phase 2 · terminated Sorafenib in Treating Patients With Relapsed Chronic Lymphocytic Leukemia · 135 trials list this drug (3 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00330421Phase 2 · completed Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07) · 135 trials list this drug (3 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Osteosarcoma,Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00134069Phase 1 · completed Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer · 135 trials list this drug (3 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00349206Phase 1 · completed Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma · 135 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436579Phase 1 · terminated Sorafenib in Treating Patients With Advanced Solid Tumors · 135 trials list this drug (3 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095693Phase 2 · terminated Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer · 135 trials list this drug (3 active) | — | — | Thyroid Gland Follicular Carcinoma,Thyroid Gland Neoplasm,Malignant Thyroid Gland Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492505Phase 2 · unknown Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma · 135 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00538005Phase 1/Phase 2 · unknown Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma · 135 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01159301Phase 1 · terminated Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia · 135 trials list this drug (3 active) | — | — | Adult Solid Neoplasm,Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492258Phase 3 · completed Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer · 135 trials list this drug (3 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01222676Phase 2 · unknown Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder · 135 trials list this drug (3 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095966Phase 2 · completed Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer · 135 trials list this drug (3 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098618Phase 2 · terminated Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer · 135 trials list this drug (3 active) | — | — | Clear Cell Renal Cell Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096395Phase 2 · completed Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer · 135 trials list this drug (3 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107432Phase 2 · completed Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. · 135 trials list this drug (3 active) | — | — | Malignant Mesothelioma,Pleural Solitary Fibrous Tumor,Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00303797Phase 1 · completed Sorafenib and Bortezomib in Treating Patients With Advanced Cancer · 135 trials list this drug (3 active) | — | — | Adult Solid Neoplasm,Multiple Myeloma,Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096512Phase 2 · completed S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · 135 trials list this drug (3 active) | — | — | Malignant Salivary Gland Neoplasm,Laryngeal Squamous Cell Carcinoma,Laryngeal Verrucous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101114Phase 2 · completed Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer · 135 trials list this drug (3 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01042041Phase 1 · completed Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer · 135 trials list this drug (3 active) | — | — | Hepatocellular Carcinoma,Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00301847Phase 2 · completed Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain · 135 trials list this drug (3 active) | — | — | Malignant Neoplasm,Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278382Phase 2 · completed Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma · 135 trials list this drug (3 active) | — | — | Anaplastic Large Cell Lymphoma,Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00119249Phase 2 · completed Sorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery · 135 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238212Phase 2 · completed S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma · 135 trials list this drug (3 active) | — | — | Gallbladder Squamous Cell Carcinoma,Malignant Gallbladder Neoplasm,Malignant Extrahepatic Bile Duct Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00131989Phase 1 · completed Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia · 135 trials list this drug (3 active) | — | — | Adult Acute Lymphoblastic Leukemia,Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118170Phase 1 · completed Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function · 135 trials list this drug (3 active) | — | — | Adult Solid Neoplasm,Multiple Myeloma,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00253578Phase 2 · completed Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma · 135 trials list this drug (3 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00767468Phase 1 · terminated Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis · 135 trials list this drug (3 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00573690Phase 1 · completed Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors · 135 trials list this drug (3 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00873002Phase 1 · terminated Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by Surgery · 135 trials list this drug (3 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01324076Phase 3 · unknown Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery · 135 trials list this drug (3 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00811759Phase 1/Phase 2 · unknown Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma · 135 trials list this drug (3 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01182272Phase 2 · unknown Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery · 135 trials list this drug (3 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00541021Phase 3 · unknown Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer · 135 trials list this drug (3 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801385Phase 2 · unknown Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy · 135 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |